Psychiatry and Neurology, Neurology · Kearney, NE
NPI
1215599311
Since 2019
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
816 22nd Ave Ste 100
Kearney, NE, 68845
Phone (308) 865-2263
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
1,360 services
Medicare patients, 2024
369
Average age 74
Drug cost, 2024
$1.4M
3,538 prescriptions
Company payments, 2025
$2,186
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sarah J Doss was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 499 times for 304 patients. In total Sarah J Doss billed 1,360 services in 28 codes, and Medicare paid $73K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 499 | 304 | $11.62 | $5,799 |
| 99215 Office E&M - Established | Facility | 315 | 204 | $97.51 | $31K |
| 99214 Office E&M - Established | Facility | 152 | 127 | $65.93 | $10K |
| 99205 Office E&M - New | Facility | 114 | 114 | $121.37 | $14K |
| 95874 Musculoskeletal | Facility | 30 | 13 | $13.79 | $414 |
| 99213 Office E&M - Established | Facility | 25 | 23 | $46.13 | $1,153 |
| 95816 Neurologic | Facility | 20 | 19 | $41.30 | $826 |
| G0444 Annual depression screening, 5 to 15 minutes | Facility | 19 | 19 | $8.23 | $156 |
| 99204 Office E&M - New | Facility | 12 | 12 | $96.14 | $1,154 |
By year: 2022 $45K for 580 services; 2023 $62K for 861 services; 2024 $73K for 1,360 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sarah J Doss prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 648 prescriptions and refills. In total Sarah J Doss wrote 3,538 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 648 | 805 | 103 | $25K |
| Donepezil Hcl Generic | 317 | 408 | 47 | $3,983 |
| Gabapentin Generic | 305 | 384 | 64 | $4,676 |
| Memantine Hcl Generic | 246 | 316 | 50 | $5,979 |
| Amantadine Amantadine Hcl | 147 | 176 | 22 | $7,172 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 143 | 170 | 26 | $5,564 |
| Levetiracetam Generic | 120 | 161 | 18 | $3,579 |
| Baclofen Generic | 118 | 149 | 28 | $2,219 |
| Buspirone Hcl Generic | 97 | 107 | 18 | $1,279 |
| Rytary Carbidopa/Levodopa | 73 | 92 | Under 11 | $80K |
| Pregabalin Generic | 68 | 76 | Under 11 | $854 |
| Trazodone Hcl Generic | 63 | 93 | 14 | $496 |
| Mirtazapine Generic | 61 | 74 | 13 | $689 |
| Quetiapine Fumarate Generic | 60 | 78 | Under 11 | $1,476 |
| Midodrine Hcl Generic | 58 | 61 | Under 11 | $1,503 |
Brand drugs: 233 claims; generic drugs: 3,305 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sarah J Doss $2,186 ($2,186 in general payments such as food, travel and fees) from 14 companies. The largest payer was Biogen, Inc. with $1,408.
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. BIIB | 3 | $1,408 |
| Abbvie Inc. ABBV | 16 | $262 |
| Argenx US, Inc. ARGX | 3 | $155 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $109 |
| Eisai Inc. 4523.T | 2 | $45.13 |
| Merz Pharmaceuticals, LLC | 2 | $34.03 |
| Boston Scientific Corporation BSX | 1 | $27.84 |
| Catalyst Pharmaceuticals, Inc. CPRX | 1 | $27.22 |
| ACADIA Pharmaceuticals Inc ACAD | 1 | $27.13 |
| Genentech USA, Inc. ROG.SW | 1 | $24.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.